- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: darusentan 100 mg
Total 14394 results
-
Ardea Biosciences, Inc.Completed
-
SandozCompleted
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States
-
SFJ Pharmaceuticals, Inc.SFJ Pharmaceuticals, Inc.Terminated
-
Mylan Pharmaceuticals IncCompleted
-
MedImmune LLCCompletedMultiple Sclerosis, Relapsing FormsUnited States, Spain, Poland, Ukraine
-
PfizerCompleted
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Terminated
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Apollomics Inc.RecruitingGastric Cancer | Pancreatic Cancer | NSCLC | Lung Cancer | Brain Tumor | Glioblastoma Multiforme | Advanced Cancer | Colon Cancer | Solid Tumors | Thyroid Cancer | Renal Cancer | Gastroesophageal Junction Adenocarcinoma | EGFR Gene Mutation | MET Amplification | HGF | MET Alteration | MET Fusion | Exon 14 SkippingUnited States, Spain, France, United Kingdom, Taiwan, Australia, Finland, Italy, Singapore, Hungary, Canada, Puerto Rico, Russian Federation
-
The Netherlands Cancer InstituteRecruitingFallopian Tube Carcinoma | Peritoneal Cancer | FIGO Stage III Ovarian CancerNetherlands
-
Daewoong Pharmaceutical Co. LTD.CompletedHealthy SubjectKorea, Democratic People's Republic of
-
Debiopharm International SACompletedHealthy VolunteersUnited Kingdom
-
OrthoTrophix, IncCompleted
-
Ionis Pharmaceuticals, Inc.CompletedHuntington's DiseaseCanada, United Kingdom, Germany
-
SandozCompletedMild and Moderate Iron-deficiency AnaemiaRussian Federation
-
University Medical Centre LjubljanaUniversity of Ljubljana School of Medicine, SloveniaCompleted
-
UCB Pharma SACompleted
-
Merck Sharp & Dohme LLCCompletedPostoperative Nausea and Vomiting | Chemotherapy-Induced Nausea and Vomiting
-
Wageningen UniversityFriesland CampinaUnknownNutrition | Metabolism | Genomics | Postprandial MetabolismNetherlands
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centre Hospitalier Universitaire, AmiensMerck Serono International SACompletedRenal Disorder Associated With Type II Diabetes MellitusFrance
-
Merck Sharp & Dohme LLCCompleted
-
VA Office of Research and DevelopmentCompletedGeneralized Anxiety DisorderUnited States
-
U.S. Army Medical Research and Development CommandCompletedGingivitis | PlaqueUnited States
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompleted
-
Virginia Commonwealth UniversityTerminatedPulmonary HypertensionUnited States
-
Nektar TherapeuticsCompletedAdvanced or Metastatic Solid Tumors in Patients With Hepatic ImpairmentUnited States
-
Pharmaceutical Research Unit, JordanCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompletedArthritis, PsoriaticBelgium, France, Israel, Italy, Germany, Bulgaria, Spain, Poland, Russian Federation, United Kingdom, Ukraine, Hungary, Portugal, Greece
-
Midnight Pharma, LLCCompletedChronic Primary InsomniaUnited States
-
University of WashingtonNational Center for Complementary and Integrative Health (NCCIH)WithdrawnUpper Respiratory Infections
-
aTyr Pharma, Inc.Foundation for Sarcoidosis ResearchCompletedPulmonary SarcoidosisUnited States
-
Janssen Research & Development, LLCBristol-Myers SquibbCompletedArthroplasty, Replacement, KneeIsrael, Belgium, Italy, United States, Spain, Hungary, Portugal, Russian Federation, Japan, Turkey, Ukraine, Greece, Poland, Argentina, Brazil, Bulgaria, Canada, South Africa
-
PfizerCompletedAtopic DermatitisUnited States, Canada
-
PfizerCompletedDermatitis, AtopicChina, United States, Australia, Poland, Hungary, Korea, Republic of, Germany, Bulgaria, Canada, Czechia, Japan, Latvia, United Kingdom
-
PfizerActive, not recruitingDermatitis, AtopicChina, United States, Spain, Taiwan, Germany, Australia, Canada, Hungary, Korea, Republic of, Poland, Serbia, Bulgaria, Czechia, Japan, Latvia, United Kingdom, Belgium, Israel, Italy, Finland, Mexico, Romania, Slovakia, Argentina, Brazil, Chil... and more
-
University of Maryland, BaltimoreMerck Sharp & Dohme LLC; Cairo UniversityWithdrawnHepatitis C Virus Infection, Response to Therapy ofEgypt
-
Castagna AntonellaBristol-Myers Squibb; ViiV HealthcareCompleted
-
PfizerCompletedSkin Diseases | Immune System Diseases | Hypersensitivity | Hypersensitivity, Immediate | Genetic Diseases, Inborn | Skin Diseases, Genetic | Dermatitis | Eczema | Skin Diseases, Eczematous | Dermatitis, AtopicUnited States, Spain, Taiwan, Germany, Canada, China, Poland, Belgium, Serbia, Brazil, Russian Federation, Israel, Latvia, Italy, Romania, Mexico, Argentina, Bulgaria, Chile, Netherlands, Slovakia
-
R-Pharm International, LLCData Management 365; K-Research, LLCCompleted
-
ORIC PharmaceuticalsTerminated
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Completed
-
Disphar International B.V.WithdrawnComparative BioavailabilityJordan
-
Chiesi Farmaceutici S.p.A.ICON plcRecruiting
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States
-
U.S. Army Medical Research and Development CommandSmithKline BeechamCompleted